Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr.

J Exp Med. 1996 Jan 1;183(1):283-7.

2.

Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.

Hokey DA, Larregina AT, Erdos G, Watkins SC, Falo LD Jr.

Cancer Res. 2005 Nov 1;65(21):10059-67.

3.

Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation.

Kim KD, Kim JK, Kim SJ, Choe IS, Chung TH, Choe YK, Lim JS.

Arch Pharm Res. 1999 Aug;22(4):340-7.

PMID:
10489871
5.

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J.

Cancer Gene Ther. 2002 Sep;9(9):778-86.

6.

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.

Gabrilovich DI, Ciernik IF, Carbone DP.

Cell Immunol. 1996 May 25;170(1):101-10.

PMID:
8665590
7.

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.

Motomura Y, Senju S, Nakatsura T, Matsuyoshi H, Hirata S, Monji M, Komori H, Fukuma D, Baba H, Nishimura Y.

Cancer Res. 2006 Feb 15;66(4):2414-22.

8.

[Enhancement of antigen presenting function of dendritic cells by IL-2 gene modification and its mechanism].

Sun L, Liu J, Cao X, Zhang M, Zhou Y, Liu B, Shi H.

Zhonghua Xue Ye Xue Za Zhi. 2002 May;23(5):247-50. Chinese.

PMID:
12133446
9.

Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.

Toes RE, Blom RJ, van der Voort E, Offringa R, Melief CJ, Kast WM.

Cancer Res. 1996 Aug 15;56(16):3782-7.

10.

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

Hu J, Yuan X, Belladonna ML, Ong JM, Wachsmann-Hogiu S, Farkas DL, Black KL, Yu JS.

Cancer Res. 2006 Sep 1;66(17):8887-96.

12.

Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.

Wan Y, Emtage P, Zhu Q, Foley R, Pilon A, Roberts B, Gauldie J.

Cell Immunol. 1999 Dec 15;198(2):131-8.

PMID:
10648127
13.

Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells.

Peiper M, Goedegebuure PS, Eberlein TJ.

Surgery. 1997 Aug;122(2):235-41; discussion 241-2.

PMID:
9288128
14.

Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.

Kozako T, Fukada K, Hirata S, White Y, Harao M, Nishimura Y, Kino Y, Soeda S, Shimeno H, Lemonnier F, Sonoda S, Arima N.

Mol Immunol. 2009 Dec;47(2-3):606-13. doi: 10.1016/j.molimm.2009.09.006. Epub 2009 Nov 3.

PMID:
19889459
15.

Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity.

Celluzzi CM, Falo LD Jr.

J Invest Dermatol. 1997 May;108(5):716-20.

16.

Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells.

Hamaoka T, Shimizu J, Suda T, Fujiwara H.

Princess Takamatsu Symp. 1988;19:265-75.

PMID:
3269360
18.

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ.

J Exp Med. 1996 Jan 1;183(1):87-97.

19.
20.

Induction of antitumor immunity using bone marrow-generated dendritic cells.

Porgador A, Snyder D, Gilboa E.

J Immunol. 1996 Apr 15;156(8):2918-26.

PMID:
8609412

Supplemental Content

Support Center